Headlines about Nu Skin Enterprises (NYSE:NUS) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern rates the sentiment of media coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Nu Skin Enterprises earned a news impact score of 0.12 on Accern’s scale. Accern also gave news coverage about the company an impact score of 45.5670065351073 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
Shares of Nu Skin Enterprises (NUS) opened at $65.56 on Friday. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.78 and a quick ratio of 1.18. Nu Skin Enterprises has a one year low of $46.76 and a one year high of $68.50. The firm has a market cap of $3,505.44, a PE ratio of 23.53, a P/E/G ratio of 2.42 and a beta of 1.57.
Nu Skin Enterprises (NYSE:NUS) last released its earnings results on Wednesday, November 1st. The company reported $0.76 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.76. Nu Skin Enterprises had a net margin of 6.97% and a return on equity of 22.38%. The business had revenue of $563.70 million during the quarter, compared to analysts’ expectations of $562.70 million. During the same quarter last year, the company earned $0.98 earnings per share. The firm’s revenue was down 6.7% on a year-over-year basis. research analysts forecast that Nu Skin Enterprises will post 3.23 EPS for the current year.
The firm also recently declared a quarterly dividend, which was paid on Wednesday, December 6th. Shareholders of record on Friday, November 17th were paid a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a yield of 2.20%. The ex-dividend date of this dividend was Thursday, November 16th. Nu Skin Enterprises’s dividend payout ratio is 52.75%.
Several equities analysts have commented on NUS shares. ValuEngine raised shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Tuesday, November 14th. Zacks Investment Research downgraded shares of Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research report on Thursday, October 5th. Three analysts have rated the stock with a sell rating, two have issued a hold rating and four have issued a buy rating to the company’s stock. Nu Skin Enterprises has a consensus rating of “Hold” and a consensus target price of $62.00.
In other Nu Skin Enterprises news, President Ryan S. Napierski sold 11,667 shares of the firm’s stock in a transaction dated Wednesday, November 1st. The shares were sold at an average price of $63.84, for a total transaction of $744,821.28. Following the completion of the transaction, the president now owns 71,634 shares in the company, valued at $4,573,114.56. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, President Ryan S. Napierski sold 6,933 shares of the firm’s stock in a transaction dated Tuesday, October 10th. The stock was sold at an average price of $64.00, for a total transaction of $443,712.00. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 68,600 shares of company stock valued at $4,298,104. Corporate insiders own 5.20% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This piece of content was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece of content on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece of content can be accessed at https://www.dispatchtribunal.com/2017/12/08/nu-skin-enterprises-nus-earns-daily-media-sentiment-rating-of-0-12.html.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.
Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.